• TBXA2R–ERM Signaling Drives TNBC Metastasis

  2026-09-15

  The reference study identifies TBXA2R as an upstream activator of ERM membrane–cytoskeleton linkers in triple-negative breast cancer, connecting GPCR signaling to motility, invasion, and metastatic colonization. Its pathway-level experiments position Gαq/11, Gα12/13, Rho GTPases, SLK, and LOK as mechanistic components of an ERM-dependent metastatic program.

• AMPK–SQSTM1 Feedback Under Metabolic Stress

  2026-09-15

  The reference study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress. This circuit coordinates lysosomal signaling, KEAP1 degradation, NRF2 activation, and antioxidant adaptation, providing a mechanistic explanation for stress tolerance in cancers with STK11 and KEAP1 pathway alterations.

• a-MSH, amide: Applied Research Workflows

  2026-09-14

  Use a-MSH, amide as a defined melanocortin stimulus for melanogenesis, receptor pharmacology, and inflammation-linked assay design. This workflow-oriented guide combines pathway controls, practical peptide handling, and troubleshooting for pigmentation regulation research and anti-inflammatory peptide research.

• Eudragit-Coated LNPs for Oral RNA Delivery

  2026-09-14

  Haque, Shrestha, and Mattheolabakis developed a pH-responsive Eudragit S 100 coating for lipid nanoparticles designed to protect RNA during gastric transit and enable release under intestinal conditions. The study combines particle characterization, nucleic-acid retention assays, simulated gastrointestinal challenges, and HEK-293 transfection to show why enteric polymer coating may improve the feasibility of oral RNA delivery.

• Olsalazine Sodium: A Transport-Aware Assay Guide

  2026-09-13

  Olsalazine Sodium is a mesalamine dimer that connects LTB4-driven inflammation with colorectal cancer tumor model research. This guide adds a transport-aware framework, using mosquito xenobiotic-clearance findings to sharpen assay controls without overstating cross-species translation.

• Angiotensin 1/2 (1-6) Research Workflows

  2026-09-12

  Use this defined Asp-Arg-Val-Tyr-Ile-His hexapeptide to connect renin-angiotensin system research with practical cardiovascular, renal, and receptor-binding assays. A structured workflow also helps investigators evaluate the emerging spike–AXL observation without overstating what an in vitro binding result means.

• Coumestrol for RA-FLS Ferroptosis Research

  2026-09-11

  Coumestrol combines nanomolar estrogen-receptor pharmacology with a practical rheumatoid arthritis fibroblast-like synoviocyte workflow centered on mitochondrial stress, iron accumulation, and PMAIP1 stability. This guide translates the reference findings into assay-ready setup, controls, troubleshooting, and comparative applications for ferroptosis and nuclear receptor research.

• DAMGO Across Scales: Interpreting MOR Pain Data

  2026-09-11

  DAMGO is a selective µ-opioid receptor agonist that reveals why receptor activation, tissue responses, and pain phenotypes may diverge. This article translates recent circuit-level findings into a practical framework for opioid receptor signaling research and chronic pain assays.

• CCK-8, Endogenous Opioids, and Morphine Withdrawal Anxiety

  2026-09-10

  This study shows that centrally administered cholecystokinin octapeptide (CCK-8) reduces withdrawal-associated anxiety in morphine-dependent rats through CCK1 receptor activity and endogenous μ-opioid signaling. Its pharmacological design separates CCK1-mediated anxiolysis from the better-known anxiogenic actions of other CCK peptides and identifies a potential mechanism for opioid addiction and withdrawal studies.

• Gramine Workflows for Ferroptosis Research

  2026-09-10

  Gramine enables mechanism-focused studies of ferroptosis rather than relying on viability measurements alone. This guide translates the reported CUL3–MTDH findings into practical cell-based, target-engagement, rescue, and optimization workflows for triple-negative breast cancer research.

• Angiotensin Peptides and SARS-CoV-2 Receptor Binding

  2026-09-09

  The 2025 reference study identifies naturally occurring angiotensin fragments as modulators of SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects observed for selected shorter and N-terminally truncated peptides. Its biochemical design connects renin-angiotensin system research with viral receptor biology while also defining important limits for interpreting binding results as evidence of infection or disease causality.

• Naloxone Beyond Overdose: A Translational Framework

  2026-09-09

  Naloxone hydrochloride is more than a canonical opioid antidote: it is a mechanistic probe for receptor signaling, neural stem cell biology, immune modulation, and behavior. This thought-leadership framework connects those applications to disciplined validation strategies and uses a PDK4 discovery program as a cross-domain model for translational decision-making.

• GRE's Anti-Melanogenic and Anti-Inflammatory Activity

  2026-09-08

  The reference study evaluates a composition of glabridin, resveratrol, and ellagic acid (GRE) across melanogenesis, oxidative-stress, and inflammatory models. Its main contribution is showing that the combined composition suppresses melanin production and tyrosinase-associated signaling while also improving DPPH scavenging and reducing nitric oxide output, providing a mechanistic basis for pigmentation regulation research.

• Ciprofloxacin Beyond Antibacterial Research

  2026-09-08

  Ciprofloxacin is best known as a fluoroquinolone antibiotic and bacterial DNA replication inhibitor, but new nanotheranostic research is expanding its translational relevance. This article connects its established topoisomerase biology with a ZIF8-based ultrasound-responsive platform for triple-negative breast cancer, while outlining practical assay, formulation, and go/no-go considerations for researchers.

• Cabazitaxel (XRP6258): Practical QC Protocol

  2026-09-07

  Cabazitaxel (XRP6258, SKU B2157) is a dossier-supported semi-synthetic taxane derivative for antiproliferative studies, microtubule dynamics disruption, and taxane-resistant cancer models. It is insoluble in water, so use DMSO- or ethanol-based preparation and avoid long-term storage of prepared solutions.

7745 records 1/517 page Next 12345 下5页 Last page